In the last trading session, 1.59 million shares of the ProPhase Labs Inc (NASDAQ:PRPH) were traded, and its beta was -0.49. Most recently the company’s share price was $0.36, and it changed around $0.04 or 12.36% from the last close, which brings the market valuation of the company to $14.96M. PRPH currently trades at a discount to its 52-week high of $5.45, offering almost -1413.89% off that amount. The share price’s 52-week low was $0.22, which indicates that the current value has risen by an impressive 38.89% since then. We note from ProPhase Labs Inc’s average daily trading volume that its 10-day average is 3.16 million shares, with the 3-month average coming to 2.27 million.
ProPhase Labs Inc (NASDAQ:PRPH) trade information
Instantly PRPH has showed a green trend with a performance of 12.36% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.4294 on recent trading dayincreased the stock’s daily price by 16.16%. The company’s shares are currently down -52.45% year-to-date, but still up 12.29% over the last five days. On the other hand, ProPhase Labs Inc (NASDAQ:PRPH) is -2.41% down in the 30-day period. We can see from the shorts that 0.46 million shares have been sold at a short interest cover period of 0.22 day(s).
The consensus price target as assigned by Wall Street analysts is $14, which translates to bulls needing to increase their stock price by 97.43% from its current value. Analyst projections state that PRPH is forecast to be at a low of $14 and a high of $14.
ProPhase Labs Inc (PRPH) estimates and forecasts
The year-over-year growth rate is expected to be 214.08%, up from the previous year.
Consensus estimates provided by 1 financial analysts predict the company will bring in an average of 3.55M in revenue for the current quarter. 1 analysts expect ProPhase Labs Inc to make 5.69M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 2.47M and 3.15M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 43.49%. Forecasts for the next quarter put sales growth at 80.86%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -57.56%.
PRPH Dividends
ProPhase Labs Inc’s next quarterly earnings report is expected to be released on 2025-May-19.
ProPhase Labs Inc (NASDAQ:PRPH)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 7.99% of ProPhase Labs Inc shares, and 12.04% of them are in the hands of institutional investors. The stock currently has a share float of 13.08%. ProPhase Labs Inc stock is held by 42.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 6.9456% of the shares, which is about 0.66 million shares worth $2.74 million.
RENAISSANCE TECHNOLOGIES LLC, with 2.3349% or 0.22 million shares worth $0.92 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 454.64 shares worth $0.16 million, making up 1.09% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 181.39 shares worth around $65300.0, which represents about 0.44% of the total shares outstanding.
